Aardvark Therapeutics (AARD) Return on Assets (QoQ) (2025 - 2026)

Aardvark Therapeutics (AARD) Return on Assets (QoQ) (2025 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	67,462.92 Bn	67,462.64 Bn	-
2	Nanobiotix	1,941.00 Bn	1,940.94 Bn	-
3	Akari Therapeutics	1,132.35 Bn	1,132.35 Bn	-
4	BeOne Medicines	473.07 Bn	468.27 Bn	1.35 Bn
5	Vertex Pharmaceuticals	123.28 Bn	116.03 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	70.12 Bn	61.37 Bn	3.31 Bn
7	Belite Bio	62.40 Bn	62.40 Bn	-
8	Argenx Se	56.45 Bn	51.27 Bn	1.41 Bn
9	Alnylam Pharmaceuticals	37.49 Bn	34.48 Bn	959.66 Mn
10	Aardvark Therapeutics	144.86 Mn	24.89 Mn	-

Download Data